No products in the cart.
Description
PRODUCT DESCRIPTION:
Albendazole Tablets 400 MG are broad-spectrum anthelmintic agents used to treat a variety of parasitic worm infestations.
As a benzimidazole carbamate derivative, Albendazole works by inhibiting the polymerization of tubulin into microtubules, thereby impairing the vital cellular processes of parasites.
This formulation ensures effective single-dose therapy for common infestations like hookworm, roundworm, whipworm, and tapeworms.
Highly suitable for mass deworming initiatives, public health programs, and individual treatment protocols.
Formulation & Presentation:
- Dosage Form: Tablets
- Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
- Available Strengths:
- Albendazole Tablets: 400 MG
- Route of Administration: Oral (As per physician’s discretion or therapeutic indication)
Therapeutic Indications:
- Treatment of single or mixed intestinal helminths
- Neurocysticercosis (caused by Taenia solium)
- Hydatid disease (caused by Echinococcus granulosus)
- As part of deworming programs in schools and communities
Side Effects:
- COMMON:
- Nausea
- Abdominal pain
- Headache
- Temporary elevation in liver enzymes
- SERIOUS (RARE):
- Bone marrow suppression (especially with long-term use)
- Hepatotoxicity
- Allergic reactions (rash, itching, swelling)
- PRECAUTIONS:
- Not recommended during pregnancy, especially in the first trimester
- Periodic liver function tests advised during prolonged therapy
- Use with caution in patients with pre-existing liver disease
- Monitor blood counts during extended courses
TECHNICAL INFORMATION
Product Specifications:
- HSN Code: To be assigned per international classification standards
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: (15x1x8 CMS)
- Shelf Life (Subject To Country Specific Guidelines): 24 to 36 months from date of manufacture or as per label specifications
- Storage: Store below 25°C. Protect from moisture, direct sunlight & children.
Regulatory Status & Supply Information:
- Regulatory Status: WHO-GMP Compliant Manufacturing. Further certifications available on request
- Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
- Stability: Zone IVB Compliant
- MOQ: Negotiable. Based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Government health ministries and public health campaigns
- NGOs and humanitarian agencies conducting mass deworming
- Importers serving schools, refugee camps, and low-resource settings
- Pharmaceutical distributors seeking WHO-GMP compliant supply
- Hospitals and clinics addressing endemic parasitic infections
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration support
- Trusted consortium network, simplifying India’s complex pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Network of audited, compliant manufacturers across India
- Customizable & Flexible branding, packaging & formulation flexibility
- End to End Logistics support flexibility & support
- Deep expertise in exporting specialty injectables & all products
CONTACT DETAILS:
- E-MAIL: hello@pharmetglobal.com
- Phone/WhatsApp Number: +91 9999091881
- Website: www.pharmetglobal.com






